Targeted Antibacterial Strategies Against Pathogens in Fish and Farm Animals
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: 30 November 2025 | Viewed by 32
Special Issue Editors
Interests: combinational antibacterial therapy; antibiotic alternatives; pharmacokinetics of antibacterial agents
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The intensification of aquaculture and terrestrial livestock production over the past decades has brought tremendous gains in global food security; however, it has also escalated the emergence and spread of bacterial diseases. Traditional reliance on broad-spectrum antibiotics in fish and farm animals has contributed to the rise of antimicrobial‐resistant strains, posing serious threats to animal health, public safety, and ecosystem balance. In response, there is growing interest in precision antibacterial approaches that selectively target pathogenic bacteria while preserving beneficial microbiota and minimizing resistance pressure.
Targeted antibacterial strategies in aquaculture and livestock production have moved beyond broad-spectrum antibiotics toward precision interventions that spare beneficial microbes and curb resistance. Bacteriophage therapy deploys viruses to kill specific pathogens like Aeromonas hydrophila or E. coli without disturbing commensals. Antimicrobial peptides puncture bacterial membranes, offering broad-spectrum activity with minimal risk of resistance. Plant-derived antimicrobial extracts—such as essential oils, tannins, and flavonoids—synergize with antibiotics to boost efficacy and lower required doses. Antimicrobial and immunostimulant probiotics outcompete pathogens and enhance host innate and adaptive immunity. Anti-quorum-sensing materials (e.g., furanones or quorum-quenching enzymes) disrupt bacterial communication to prevent biofilm formation and virulence. Advanced delivery systems—liposomes, polymeric nanoparticles, and biodegradable hydrogels—ensure precise, controlled release at infection sites. Tailored vaccines, often combined with adjuvants or cytokine stimulants, induce robust, pathogen-specific immune responses in fish and livestock. CRISPR-Cas antimicrobials can be programmed to cleave resistance or virulence genes within bacterial populations. Together, these approaches form a sustainable, resistance-aware toolkit for safeguarding animal health and food safety.
The aim of this Special Issue is to bring together comprehensive research on fish pharmacokinetics, farm-animal pharmacokinetics, pharmacodynamics, dosing regimen design, antibiotic adjuvants, and probiotics and to establish a multidisciplinary discussion group. By compiling and sharing this wide-ranging information, we seek to foster collaborative dialogue and accelerate innovation in targeted antimicrobial strategies across aquaculture and livestock production.
References:
- Prestinaci F.; Pezzotti P.; Pantosti A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog. Glob. Health 2015 109, 309–318
- Birhanu BT, Lee E-B, Park S-C (2020) Evaluation of the pharmacokinetic-pharmacodynamic integration of marbofloxacin in combination with methyl gallate against Salmonella Typhimurium in rats. PLoS ONE 15(6): e0234211. https://doi.org/10.1371/journal.pone.0234211.
- Chae Hong Rhee, Seung-Chun Park, Moon Her and Wooseog Jeong. Surrogate Selection for Foot-and-Mouth Disease Virus in Disinfectant Efficacy Tests by Simultaneous Comparison of Bacteriophage MS2 and Bovine Enterovirus Type 1. Viruses.: 22 November 2022, Viruses 2022, 14, 2590. https://doi.org/10.3390/v14122590.
Prof. Dr. Seung-Chun Park
Prof. Dr. Eon Bee Lee
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- aquaculture and livestock pharmacokinetics
- precision antibacterial interventions
- antibiotic adjuvants and probiotics
- targeted drug delivery systems
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.